| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.19 | 2e-06 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.19 | 3e-06 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.19 | 4e-06 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.18 | 4e-06 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.19 | 5e-06 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.16 | 5e-06 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.17 | 6e-06 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | -0.19 | 7e-06 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.18 | 8e-06 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.18 | 8e-06 |